🇺🇸 FDA
Patent

US 8287876

Recombinant chimeric antigens for diagnosis and prevention of scrub typhus

granted A61PA61P31/04A61P33/02

Quick answer

US patent 8287876 (Recombinant chimeric antigens for diagnosis and prevention of scrub typhus) held by United States of America as represented by the Secretary of the Air Force expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61P, A61P31/04, A61P33/02, A61P37/04